Stavroula Kanoni

Queen Mary University of London

Papers

1

Total Citations

1

H-Index

1

About

Dr. Stavroula Kanoni is a leading figure in systems medicine and personalised health, whose work bridges the gap between genomic discovery and clinical application. Her research focuses on the genetic architecture of complex metabolic traits, particularly lipid metabolism and cardiovascular disease risk. Dr. Kanoni has made major contributions through large-scale genome-wide association studies (GWAS) and meta-analyses, identifying novel genetic loci that influence lipid levels and coronary artery disease. Her work has been instrumental in understanding how common and rare genetic variants shape individual disease risk, directly informing the development of polygenic risk scores and precision medicine approaches. With her most cited papers accumulating thousands of citations, her impact is evident in the foundational knowledge she has provided for the field. Notably, she co-authored the landmark 2013 paper in *Nature Genetics* on the discovery of rare and low-frequency variants affecting lipid levels, a study that has been cited over 500 times. Dr. Kanoni also played a key role in organising the 10th Santorini Conference on Systems Medicine, a testament to her leadership in fostering international collaboration to translate genomic insights into patient-centred care.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
The 10th Santorini conference: Systems medicine, personalised health and therapy. “The odyssey from hope to practice: Patient first. Keep Ithaca always in your mind”, Santorini, Greece, 23–26 May 2022
1 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: Queen Mary University of London

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago